600422.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 10:00):

Stats
Dzisiejszy wolumen	10.16M
Średni wolumen	9.22M
Kapitalizacja rynkowa	17.93B
EPS	CNY0.223 ( 2023-10-27 )
Następna data zysków	( CNY0 ) 2024-06-28
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	40.83
ATR14	CNY0.0330 (0.14%)

Wolumen Korelacja

Długi: 0.56 (weak)

Krótki: -0.80 (moderate negative)

Signal:(42.08) Neutral

KPC Pharmaceuticals, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

KPC Pharmaceuticals, Inc. Korelacja - Waluta/Towar

0.00
( neutral )

0.29
( neutral )

0.00
( neutral )

-0.01
( neutral )

0.48
( neutral )

0.61
( weak )

KPC Pharmaceuticals, Inc. Finanse

Annual	2023
Przychody:	CNY7.63B
Zysk brutto:	CNY3.28B (43.04 %)
EPS:	CNY0.590

FY	2023
Przychody:	CNY7.63B
Zysk brutto:	CNY3.28B (43.04 %)
EPS:	CNY0.590

FY	2022
Przychody:	CNY8.28B
Zysk brutto:	CNY3.44B (41.52 %)
EPS:	CNY0.510

FY	2021
Przychody:	CNY8.25B
Zysk brutto:	CNY3.41B (41.30 %)
EPS:	CNY0.669

Financial Reports:

No articles found.

KPC Pharmaceuticals, Inc.

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.